The SENTIREC-endo study - Risks and benefits of a national adoption of sentinel node mapping in low and intermediate risk endometrial cancer

Autor: Sarah Marie Bjørnholt, Sarah Elizabeth Sponholtz, Ole Mogensen, Kirsten Bouchelouche, Erik Thorlund Parner, Gudrun Neumann, Kirsten Marie Jochumsen, Bushra Hassan Hamid, Morten Bülow Davidsen, Signe Frahm Bjørn, Katja Dahl, Pernille Tine Jensen

Publikováno v: Bjørnholt, S M, Sponholtz, S E, Mogensen, O, Bouchelouche, K, Parner, E T, Neumann, G, Jochumsen, K M, Hamid, B H, Davidsen, M B, Bjørn, S F, Dahl, K & Jensen, P T 2023, ' The SENTIREC-endo study-Risks and benefits of a national adoption of sentinel node mapping in low and intermediate risk endometrial cancer ', Gynecologic Oncology, vol. 171, pp. 121-128 . https://doi.org/10.1016/j.ygyno.2023.02.013

OBJECTIVE: The SENTIREC-endo study aims to investigate risks and benefits of a national protocolled adoption of sentinel lymph node (SLN) mapping in women with early-stage low-grade endometrial cancer (EC) with low- (LR) and intermediate-risk (IR) of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e6d2b7aaf909e73c6476f1c79861cde
https://pure.au.dk/portal/da/publications/the-sentirecendo-study--risks-and-benefits-of-a-national-adoption-of-sentinel-node-mapping-in-low-and-intermediate-risk-endometrial-cancer(d012039c-8289-4fcf-97df-61679f6fe5c0).html